LGVN.NASDAQLongeveron INC

Form 4: Longeveron Inc. Director Joshua Hare Sells 5,250 Shares

Sentiment:

SEC Form 4 Filing


Joshua Hare, Chief Scientific Officer and Director at Longeveron Inc., sold 5,250 shares of Class A Common Stock at a weighted average price of $1.4033 on May 16, 2025.

Summary

  • On May 16, 2025, Joshua Hare, a Director and the Chief Scientific Officer of Longeveron Inc. (LGVN), sold 5,250 shares of Class A Common Stock.
  • The shares were sold at a weighted average price of $1.4033, with individual transaction prices ranging from $1.40 to $1.42.
  • Following the transaction, Hare directly owns 721,796 shares, which includes RSUs subject to future vesting and 462,807 shares of Class B common stock.
  • Class B common stock has identical rights to common stock, except each share is entitled to 5 votes and is convertible into one share of common stock.

Sentiment

Score: 5

Explanation: The document is a neutral report of a stock sale by a company insider. It doesn't inherently convey positive or negative sentiment.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity. It provides transparency to the market regarding the transactions of company executives and directors.

Stakeholder Impact

  • The sale of shares by a company insider could be perceived negatively by some shareholders, although the amount is relatively small.

Key Dates

DateDescription
05/16/2025Date of transaction: Joshua Hare sold 5,250 shares of Class A Common Stock.

Keywords

Longeveron Inc., Joshua Hare, stock sale, Class A Common Stock, Class B Common Stock, insider trading, Form 4, LGVN

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.